Results 91 to 100 of about 9,430 (168)

Morphea Induced by Golimumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review. [PDF]

Clin Case Rep
Hilwanjee F, Alghabra Y, Aldalati R, Al Chama N.   +3 more
europepmc   +1 more source

Model-Based Design of Sustained-Release Formulations of Anti-TNF-α Monoclonal Antibodies for Intravitreal Administration. [PDF]

Pharmaceutics
Reig-López J, Cuquerella-Gilabert M, Zarzoso-Foj J, Mangas-Sanjuán V, Merino V, Merino-Sanjuán M.   +5 more
europepmc   +1 more source

Biosimilars in Adult and Pediatric Noninfectious Uveitis. [PDF]

Clin Ophthalmol
Ploeger CG, Carvalho Soares Valentim C, Guner ME, Kabaalioglu Guner M.   +3 more
europepmc   +1 more source

Therapy Persistence and Dose Escalation of Advanced Treatments in First and Second Line of Ulcerative Colitis and Crohn's Disease - A Retrospective Cohort Analysis of Healthcare Claims Data. [PDF]

Z Gastroenterol
Dignass A, Teich N, Kaiser S, Sünwoldt J, Reinhard E, Borchert J, Kudernatsch R.   +6 more
europepmc   +1 more source

Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications. [PDF]

Clin Exp Gastroenterol
Koivusalo M, Jokelainen J, Huhtinen A, Kovac B, Silvola S, Torvinen S, Ylisaukko-Oja T, Arkkila P.   +7 more
europepmc   +1 more source

Real-World Effectiveness of Golimumab in Ulcerative Colitis: A Pooled Analysis from the Prospective UMBRELLA-IBD Registry in Germany. [PDF]

J Clin Med
Bokemeyer A, Wenske T, Plachta-Danielzik S, Bokemeyer B.   +3 more
europepmc   +1 more source

Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. [PDF]

United European Gastroenterol J
Hart A, Navabi S, D'Haens G, Matsuoka K, Martín-Arranz MD, Atreya R, Samaan KH, Dhesi E, Redondo I, Zhu B, Paulissen J, Zaremba-Pechmann L, Baygani S, Limdi J, Laharie D, Danese S.   +15 more
europepmc   +1 more source

Thyroid hormone changes after tumor necrosis factor inhibitor therapy in euthyroid patients with rheumatic diseases. [PDF]

BMC Pharmacol Toxicol
Kizilkaya B, Mercantepe F, Vekic J, Cure O, Klisic A.   +4 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study. [PDF]

J Clin Med
Gasparini RG, Taxonera C, Júnior AJTA, Schiavetti BLP, Penna FGCE, Magalhães RB, da Costa Ferreira S, de Sá Brito Fróes R, Dos Santos CHM, Flores C, da Silva BC, Parra RS, Chagas EFB, Venâncio A, Rzetelna H, Rosa CFPPA, Andrade AR, Freire CCF, Faria MAG.   +18 more
europepmc   +1 more source

Tumor necrosis factor-alpha-mediated inflammatory bone loss: Pathogenic mechanisms and therapeutic potential of its inhibitors. [PDF]

Tzu Chi Med J
Lin WY, Pan YJ, Yeh KT, Su KY, Dharini KK, Chen IH, Wu WT, Lin MD, Peng CH.   +8 more
europepmc   +1 more source